News

Lyra Mental Health Care Reduces Overall Medical Claims Costs for Employers

by

Independent third party peer-reviewed research demonstrates long-term cost savings of approximately $2,300 per participant per year BURLINGAME, Calif., May 16, 2023 /PRNewswire/ — Lyra Health, the leading provider of innovative Workforce Mental Health solutions for employers, today announced the release of a peer-reviewed study confirming that Lyra’s mental health care benefits help organizations reduce overall … Read more

BUFFALO REHAB GROUP NOW FEATURING TRAZER®

by

Buffalo Rehab Group a Committed Provider of Start-to-Finish Physical & Occupational Therapy in Western New York is leveraging TRAZER in Community Outreach CLEVELAND, May 16, 2023 /PRNewswire/ — TRAZER, an innovative leader in technology designed for rehabilitation, strengthening, and enhancing athletic performance, is pleased to welcome Buffalo Rehab Group (BRG) to its client roster. Aligned … Read more

Fingerprint Now Available on Auth0 Marketplace

by

Authenticate users in real-time with highly accurate device identification combined with the power of Auth0 CHICAGO, May 16, 2023 /PRNewswire/ –Today, Fingerprint, the world’s most accurate device identifier, announced the availability of Fingerprint Pro on Auth0 Marketplace, a catalog of trusted technology integrations to extend the functionality of Okta Customer Identity Cloud, powered by Auth0. This … Read more

Orbis and partners mark historic 100 millionth dose of sight-saving antibiotic azithromycin in the fight to eliminate blinding trachoma in Ethiopia by 2030

by

Milestone achieved 20 years after Orbis began leading mass drug administrations NEW YORK, May 16, 2023 /PRNewswire/ — Eye care nonprofit Orbis International today announced that it has distributed 100 million doses of azithromycin antibiotics in Ethiopia. This is part of ongoing efforts to eliminate trachoma, an infectious, painful, and blinding eye disease, by 2030, in line … Read more

Inhibikase Therapeutics Announces Dosing of First Patient in its Phase 2 ‘201’ Clinical Trial of IkT-148009 to Treat Parkinson’s Disease

by

BOSTON and ATLANTA, May 16, 2023 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson’s disease and related disorders, today announced that the first patient has been dosed in its Phase 2 ‘201’ trial evaluating IkT-148009, the Company’s novel Abelson Tyrosine Kinase, or c-Abl, … Read more

Palatin Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

by

Phase 3 PL9643 Data in Patients with Dry Eye Disease Presented at KOL Event Analysis of Lead-In Population of Initial 120 Patients Showed Statistical Separation for Clinical Efficacy Across Multiple Signs and Symptoms of Dry Eye along with Excellent Patient Safety and Tolerability Final Data Expected Second Half Calendar Year 2023 Phase 2 Clinical Study … Read more

BOTTICELLI, L’INQUIÉTUDE ET LA BEAUTÉ

by

FLORENCE, Italie, 16 mai 2023 /PRNewswire/ — Artiste à succès, interprète sensible de la culture de son temps et auteur d’œuvres d’une extraordinaire pertinence, Sandro Botticelli était un maître de la beauté. Avec ses « Vénus », il a établi, sans le savoir, un canon de perfection qui reflète étroitement celui de l’époque moderne. Pourtant, il était un … Read more

BOTTICELLI, LA INQUIETUD Y LA BELLEZA — Menarini presenta en Florencia su última monografía de arte, dedicada al símbolo del renacimiento italiano

by

FLORENCIA, Italia, 16 de mayo de 2023 /PRNewswire/ — Artista de éxito, intérprete sensible de la cultura de su tiempo y autor de obras de extraordinaria relevancia, Sandro Botticelli fue un maestro de la belleza. Con sus “Venus”, estableció, sin saberlo, un canon de perfección que refleja fielmente el de la actualidad.  Sin embargo, era una figura … Read more

Sunshine Health and Johns Hopkins All Children’s Care Network Enter Value-Based Care Agreement to Better Serve Medicaid Recipients

by

Partnership provides in-network access with more than 160 primary care providers serving 56,000 Sunshine Health members TAMPA, Fla., May 16, 2023 /PRNewswire/ — Sunshine Health, a leading Medicaid managed care organization in Florida, and Johns Hopkins All Children’s Hospital, a premiere clinical and academic health system providing expert pediatric care for infants, children and teens … Read more

NRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

by

Enrollment continues in the Phase 2b/3 clinical trial evaluating NRX-101 in Suicidal Treatment-Resistant Bipolar Depression; data expected in 4Q 2023 National educational campaign launched to further accelerate enrollment in Breakthrough Therapy Designation meeting for NRX-101 in Suicidal Treatment-Resistant Bipolar Depression with the U.S. FDA planned for 2Q 2023; on track to report topline clinical data … Read more